Methamphetamine & Stimulant-Focused Virtual Events at ADAI (May & June 2025)
05/08/2025
Deaths from methamphetamine have been rising over the past decade, with most counties in Washington State seeing significant increases.
Small counties like Okanogan and Pend Oreille went from well below the state average to well above, while larger counties like Snohomish, King, Pierce, and Spokane saw methamphetamine poisoning rates increase by 10-fold or more. (Data from our Washington State Opioid/Major Drug Interactive Data site.)
To help address this important public health issue, multiple teams at ADAI are hosting a range of (virtual) educational events in the coming months focused on methamphetamine and other stimulant use. Check out the list below and sign up for any you’re interested in attending! All are welcome!
June 12, 2025
Focus on Meth Virtual Symposium (CEDEER)
The ADAI Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER) has been hosting a Focus on Meth series this spring, featuring several 1-hour webinars on a range of meth-related topics and a collection of related resources.
On June 12, 2025 (9am-3:30pm PT), the series ends with a day-long virtual symposium focused on the scope and impact of methamphetamine use in Washington State and ways to best support people across a spectrum of health care, harm reduction, and treatment needs.
The symposium will blend data and education on treatment medications and interventions with real-world perspectives on harm reduction and recovery from people with lived experience of meth use.
Register for the June 12 Symposium
May 21, 2025
Medical Complications of Methamphetamine Use: Strategies for Prevention, Harm Reduction, and Treatment (Northwest ATTC)
12:00pm – 1:00pm PT
Presented by Sarah Leyde, MD (University of Washington)
Certificate of attendance available for all attendees.
This webinar from the Northwest ATTC (located at ADAI) will explore key clinical challenges and evidence-based strategies to improve care for individuals who use methamphetamine. Attendees will learn to recognize common health problems related to methamphetamine use, apply prevention and treatment strategies, and develop an approach to addressing infectious complications. The session will also highlight best practices in care coordination and interprofessional collaboration to improve outcomes in this high-risk population.
Register for the medical complications session
June 25, 2025
Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder (Northwest ATTC)
11:00am – 12:30pm PT
Presented by Kathleen T. Brady, MD, PhD (Medical University of South Carolina)
CME / CE credits available for all attendees of this session!
In this webinar, Dr. Brady will talk about the NIDA Clinical Trials Network (CTN) study CTN-0108, Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder, a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder.
Dr. Brady, co-PI for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.
This session is sponsored by the Northwest ATTC, Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network.
June 2, 9, & 16, 2025
Stimulant Health Matters Series (State Opioid Response training team)
12:00pm-1:00pm PT
This 3-part online series from the Washington State Opioid Response Training Team will bring together leading experts to discuss evidence-based interventions to address simulant-related health needs.
Healthcare experts will present actionable strategies for:
- Neuropsychiatry & mental health
- Wound care & skin health
- Cardiovascular monitoring & treatment
Presenters
- Kayla Cross, MSN, MA, ARNP, PMHNP-BC, Bloom Psychiatry & Veterans Health Administration
- Hailey Heilman BSN, RN, CWON, CHAS Lead Care Team
- Emily Fejeran, BSN, RN, CHAS Street Medicine
Danee Hidano, MD, Cardiology, Harborview Medical Center
